FOI/25/216
Read more about this page below
Reference | FOI/25/216 |
---|---|
Description | Community Respiratory Service |
Date requested | 09/10/2024 |
Attachments |
Request
1. Community Respiratory Service Mapping
Does your organisation provide community-based bronchiectasis services?
Does your organisation provide services dedicated to complex bronchiectasis e.g. those with frequent exacerbations, or comorbidities?
Does your organisation provide community-based services treat complex respiratory conditions such as COPD, interstitial lung disease?
If yes, please complete the table below:
Name of provider
Number of patients contracted/treated in the past year
Address of provider
2. High-cost drug propensity
Are the community service providers authorised to treat patients with any of the following drug types?
· Monoclonal antibodies
· Nebulised or infusion polymyxins / aminoglycosides antibiotics e.g. Colomycin or Gentamicin
· Other high-cost drugs
3. Resource utilisation
What is the total resource funding utilisation in social care for exacerbating bronchiectasis, in the last financial year?
What/how much is funded from NHS budgets?
What/how much is funded by social care budgets?
Response
Please see attached